Holdco Nuvo Group D.G Ltd. Ordinary Shares

Healthcare US NUVO

0.002USD
-0.001(33.33%)

Last update at 2024-11-19T14:30:00Z

Day Range

0.0020.003

LowHigh

52 Week Range

1.4812.15

LowHigh

Fundamentals

Previous Close 0.003
Market Cap49.23M
Volume735
P/E Ratio-
Dividend Yield-%
EBITDA-24.02200M
Revenue TTM0.00000M
Revenue Per Share TTM-
Gross Profit TTM 0.00000M
Diluted EPS TTM-2.23

Overview
Financials
Peer Comparison
Reports
Stock Research & News

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly
Date	2023-12-31	2022-12-31	2021-12-31
Income before tax	-34.69400M	-19.90400M	-34.07900M
Minority interest	-	-	-
Net income	-33.65500M	-20.67900M	-34.51200M
Selling general administrative	8.29M	10.91M	17.10M
Selling and marketing expenses	-	-	-
Gross profit	-0.01500M	0.00000M	0.00000M
Reconciled depreciation	0.21M	0.49M	0.21M
Ebit	-	-	-
Ebitda	-	-	-
Depreciation and amortization	-	-	-
Non operating income net other	-	-	-
Operating income	-16.63300M	-20.80600M	-27.56600M
Other operating expenses	-	-	-
Interest expense	0.04M	0.07M	0.56M
Tax provision	-1.03900M	0.78M	0.43M
Interest income	-	-	-
Net interest income	-0.04400M	-0.06900M	-0.56500M
Extraordinary items	-	-	-
Non recurring	-	-	-
Other items	-	-	-
Income tax expense	-	-	-
Total revenue	0.18M	0.00000M	0.00000M
Total operating expenses	16.81M	20.81M	27.57M
Cost of revenue	0.19M	0.00000M	0.00000M
Total other income expense net	-18.01700M	0.97M	-5.94800M
Discontinued operations	-	-	-
Net income from continuing ops	-33.65500M	-20.67900M	-34.51200M
Net income applicable to common shares	-	-	-
Preferred stock and other adjustments	-	-	-

Breakdown	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly
Date	2023-12-31	2022-12-31	2021-12-31
Total assets	3.49M	3.75M	7.44M
Intangible assets	-	-	-
Earning assets	-	-	-
Other current assets	0.36M	0.31M	-
Total liab	70.98M	42.45M	33.28M
Total stockholder equity	-67.49000M	-38.70400M	-25.83900M
Deferred long term liab	-	-	-
Other current liab	16.06M	26.28M	26.58M
Common stock	-	-	-
Capital stock	0.04M	0.04M	0.04M
Retained earnings	-143.77400M	-110.11900M	-89.44000M
Other liab	-	-	-
Good will	-	-	-
Other assets	-	-	-
Cash	0.55M	0.84M	4.60M
Cash and equivalents	-	-	-
Total current liabilities	30.95M	42.04M	32.90M
Current deferred revenue	-	-	-
Net debt	11.02M	8.27M	-
Short term debt	-	-	-
Short long term debt	10.63M	9.11M	-
Short long term debt total	-	-	-
Other stockholder equity	-	-	-
Property plant equipment	-	-	-
Total current assets	1.58M	2.60M	5.78M
Long term investments	-	-	-
Net tangible assets	-	-	-
Short term investments	-	-	-
Net receivables	0.04M	0.00000M	-
Long term debt	0.95M	-	-
Inventory	0.02M	0.54M	0.52M
Accounts payable	0.95M	0.98M	0.36M
Total permanent equity	-	-	-
Noncontrolling interest in consolidated entity	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-
Accumulated other comprehensive income	-	-	-
Additional paid in capital	-	-	-
Common stock total equity	-	-	-
Preferred stock total equity	-	-	-
Retained earnings total equity	-	-	-
Treasury stock	-	-	-
Accumulated amortization	-	-	-
Non currrent assets other	1.17M	0.03M	0.31M
Deferred long term asset charges	-	-	-
Non current assets total	1.91M	1.14M	1.66M
Capital lease obligations	-	-	-
Long term debt total	-	-	-

Breakdown	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly
Date	2023-12-31	2022-12-31	2021-12-31
Investments	-0.03800M	-0.27700M	-0.26300M
Change to liabilities	-	-	-
Total cashflows from investing activities	-	-	-
Net borrowings	-	-	-
Total cash from financing activities	14.44M	9.82M	18.41M
Change to operating activities	-	-	-
Net income	-33.65500M	-20.67900M	-34.51200M
Change in cash	-0.56100M	-3.86200M	3.78M
Begin period cash flow	1.14M	5.00M	1.23M
End period cash flow	0.58M	1.14M	5.00M
Total cash from operating activities	-14.95600M	-13.47100M	-14.35400M
Issuance of capital stock	13.00M	0.00000M	0.00000M
Depreciation	0.21M	0.49M	0.21M
Other cashflows from investing activities	-	-	-
Dividends paid	-	-	-
Change to inventory	0.52M	-0.01600M	-0.35200M
Change to account receivables	-0.04000M	0.00000M	0.00000M
Sale purchase of stock	-	-	-
Other cashflows from financing activities	-	-	-
Change to netincome	-	-	-
Capital expenditures	0.04M	0.25M	0.24M
Change receivables	-	-	-
Cash flows other operating	-	-	-
Exchange rate changes	-	-	-
Cash and cash equivalents changes	-	-	-
Change in working capital	-1.62400M	1.45M	0.82M
Stock based compensation	3.10M	7.77M	9.75M
Other non cash items	-0.99500M	-1.56200M	3.46M
Free cash flow	-14.99400M	-13.72400M	-14.59200M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)
NUVO Holdco Nuvo Group D.G Ltd. Ordinary Shares	-0.001 33.33%	0.002	-	-	-	-
ABT Abbott Laboratories	-1.2 1.02%	115.93	37.15	23.15	4.67	4.97	4.88	19.38
SYK Stryker Corporation	-3.03 0.78%	385.65	44.07	24.94	5.51	6.12	6.05	25.73
MDT Medtronic PLC	-0.92 1.08%	84.08	26.60	15.87	3.35	2.08	3.90	14.12
BSX Boston Scientific Corp	0.18 0.20%	90.51	68.17	24.57	5.85	4.26	6.46	26.80

Reports Covered

View All

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.